相似文献
1
Increased erythrocyte mean corpuscular volume by methotrexate predicts clinical response in psoriatic arthritis.
Rheumatology (Oxford). 2022 Aug 30;61(9):e270-e273. doi: 10.1093/rheumatology/keac276.
2
Methotrexate in psoriatic arthritis.
Joint Bone Spine. 2014 Mar;81(2):107-9. doi: 10.1016/j.jbspin.2013.10.005. Epub 2014 Mar 12.
3
Methotrexate therapy for psoriatic arthritis: reappraisal of an old remedy.
J Rheumatol. 2008 Mar;35(3):369-71.
4
Methotrexate use in psoriasis and psoriatic arthritis.
Rheum Dis Clin North Am. 1997 Nov;23(4):797-809. doi: 10.1016/s0889-857x(05)70361-6.
5
Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis.
Mod Rheumatol. 2015 May;25(3):431-4. doi: 10.3109/14397595.2014.958891. Epub 2014 Oct 8.
6
The role of methotrexate in psoriatic arthritis: what is the evidence?
Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S94-7. Epub 2015 Oct 15.
7
Role of Methotrexate in the Management of Psoriatic Arthritis.
Drugs. 2018 Apr;78(6):611-619. doi: 10.1007/s40265-018-0898-2.
8
Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?
Nat Rev Rheumatol. 2012 May 2;8(5):251-2. doi: 10.1038/nrrheum.2012.56.
9
Do Biologic-treated Psoriatic Arthritis Patients with Spondylitis Respond Differently with or without Concomitant Methotrexate from Patients without Spondylitis?
J Rheumatol. 2016 Mar;43(3):471-3. doi: 10.3899/jrheum.160046.
10
Methotrexate: new indication. Psoriatic arthritis: approved at last.
Prescrire Int. 2007 Oct;16(91):182.
引用本文的文献
1
An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis.
J Rheum Dis. 2025 Jan 1;32(1):30-37. doi: 10.4078/jrd.2024.0073. Epub 2024 Sep 2.
本文引用的文献
1
The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume.
Rheumatology (Oxford). 2022 Feb 2;61(2):787-793. doi: 10.1093/rheumatology/keab403.
2
Methotrexate therapy impacts on red cell distribution width and its predictive value for cardiovascular events in patients with rheumatoid arthritis.
BMC Rheumatol. 2018 Mar 7;2:6. doi: 10.1186/s41927-018-0012-0. eCollection 2018.
3
Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.
PLoS One. 2018 Dec 10;13(12):e0208534. doi: 10.1371/journal.pone.0208534. eCollection 2018.
4
Prediction of response to methotrexate in rheumatoid arthritis.
Expert Rev Clin Immunol. 2018 May;14(5):419-429. doi: 10.1080/1744666X.2018.1465409. Epub 2018 Apr 26.
5
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13.
6
The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies--a systematic review.
Eur J Clin Pharmacol. 2015 Apr;71(4):411-23. doi: 10.1007/s00228-015-1819-x. Epub 2015 Feb 18.
7
Methotrexate for ankylosing spondylitis.
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD004524. doi: 10.1002/14651858.CD004524.pub4.
8
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.
Rheumatology (Oxford). 2012 Aug;51(8):1368-77. doi: 10.1093/rheumatology/kes001. Epub 2012 Feb 17.
9
Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis.
Drug Metab Pharmacokinet. 2012;27(2):192-9. doi: 10.2133/dmpk.dmpk-11-rg-066. Epub 2011 Nov 22.
10
Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis.
Rheumatology (Oxford). 2010 Dec;49(12):2337-45. doi: 10.1093/rheumatology/keq216. Epub 2010 Aug 16.
Zotero 插件